Items-$0.00
Email:sales@ruixibiotech.com
Tel.:02988811435
CNX-2006 CAS：1375465-09-0
CNX-2006
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1482 | 25mg | 265.00 | + Add to cart |
|
| R-C-1482 | 50mg | 465.00 | + Add to cart |
|
| R-C-1482 | 100mg | 740.00 | + Add to cart |
|
|
|
||||
Product description
CNX-2006 is a potent,mutant-selective EGFR inhibitor with excellent in vitro activity in cells with activating EGFR mutations, as well as in cells harbouring the T790M mutation.CNX-2006 is the prototype for CO-1686,which is currently in a Phase I clinical trial for the treatment of EGFR-mutant lung cancer.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
msds---CNX-2006 Related Product
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com
